FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105079905> ?p ?o ?g. }

• W2105079905 endingPage "2299" @default.
• W2105079905 startingPage "2292" @default.
• W2105079905 abstract "Abstract Poor immune reconstitution after haploidentical stem cell transplantation results in a high mortality from viral infections and relapse. One approach to overcome this problem is to selectively deplete the graft of alloreactive cells using an immunotoxin directed against the activation marker CD25. However, the degree of depletion of alloreactive cells is variable following stimulation with recipient peripheral blood mononuclear cells (PBMCs), and this can result in graft versus host disease (GVHD). We have refined this approach using recipient Epstein-Barr virus (EBV)–transformed lymphoblastoid cell lines (LCLs) as stimulators to activate donor alloreactive T cells. Our studies demonstrate that allodepletion with an anti-CD25 immunotoxin following stimulation with HLA-mismatched host LCLs more consistently depleted in vitro alloreactivity than stimulation with host PBMCs, as assessed in primary mixed lymphocyte reactions (MLRs). Allodepletion using this approach specifically abrogates cytotoxic T-cell responses against host LCLs. In interferon-γ (IFN-γ) enzyme-linked immunospot (ELISPOT) assays, antiviral responses to adenovirus and cytomegalovirus (CMV) were preserved following allodepletion. Likewise, using HLA-A2–pp65 tetramers, we have shown that the frequency of CMV-specific T cells is unaffected by allodepletion. Moreover, the donor anti-EBV response is partially retained by recognition of EBV antigens through the nonshared haplotype. Finally, we studied whether allodepletion affects the response to candidate tumor antigens in myeloid malignancies. Using HLA-A2–PR1 tetramer analysis, we found that the frequency of T cells recognizing the PR1 epitope of proteinase 3 was not significantly different in allodepleted and unmanipulated PBMCs from patients with chronic myeloid leukemia (CML) undergoing transplantation. Based on these data, we have embarked on a phase 1 clinical trial of addback of allo-LCL–depleted donor T cells in the haplo-identical setting." @default.
• W2105079905 created "2016-06-24" @default.
• W2105079905 creator A5002774261 @default.
• W2105079905 creator A5006134549 @default.
• W2105079905 creator A5021029688 @default.
• W2105079905 creator A5023064016 @default.
• W2105079905 creator A5024390284 @default.
• W2105079905 creator A5039227763 @default.
• W2105079905 creator A5047120478 @default.
• W2105079905 creator A5047806967 @default.
• W2105079905 creator A5057196933 @default.
• W2105079905 creator A5058287032 @default.
• W2105079905 creator A5073776230 @default.
• W2105079905 creator A5077357181 @default.
• W2105079905 creator A5084475433 @default.
• W2105079905 creator A5086465061 @default.
• W2105079905 creator A5090391845 @default.
• W2105079905 date "2003-09-15" @default.
• W2105079905 modified "2023-10-03" @default.
• W2105079905 title "Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses" @default.
• W2105079905 cites W1482758361 @default.
• W2105079905 cites W1503279681 @default.
• W2105079905 cites W159030646 @default.
• W2105079905 cites W1590531419 @default.
• W2105079905 cites W1737344958 @default.
• W2105079905 cites W1931699789 @default.
• W2105079905 cites W2001070274 @default.
• W2105079905 cites W2008036289 @default.
• W2105079905 cites W2014888025 @default.
• W2105079905 cites W2019517733 @default.
• W2105079905 cites W2028593992 @default.
• W2105079905 cites W2058053814 @default.
• W2105079905 cites W2058136494 @default.
• W2105079905 cites W2068136360 @default.
• W2105079905 cites W2069987316 @default.
• W2105079905 cites W2089037140 @default.
• W2105079905 cites W2090089773 @default.
• W2105079905 cites W2095220820 @default.
• W2105079905 cites W2116187825 @default.
• W2105079905 cites W2122171046 @default.
• W2105079905 cites W2147068163 @default.
• W2105079905 cites W2149936872 @default.
• W2105079905 cites W2158500407 @default.
• W2105079905 cites W2176559485 @default.
• W2105079905 cites W2237258466 @default.
• W2105079905 cites W2262568580 @default.
• W2105079905 cites W2317548431 @default.
• W2105079905 cites W2318698174 @default.
• W2105079905 cites W2334996664 @default.
• W2105079905 cites W2336061803 @default.
• W2105079905 cites W2440566362 @default.
• W2105079905 cites W319578897 @default.
• W2105079905 cites W998391454 @default.
• W2105079905 doi "https://doi.org/10.1182/blood-2002-11-3516" @default.
• W2105079905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12763937" @default.
• W2105079905 hasPublicationYear "2003" @default.
• W2105079905 type Work @default.
• W2105079905 sameAs 2105079905 @default.
• W2105079905 citedByCount "148" @default.
• W2105079905 countsByYear W21050799052012 @default.
• W2105079905 countsByYear W21050799052013 @default.
• W2105079905 countsByYear W21050799052014 @default.
• W2105079905 countsByYear W21050799052015 @default.
• W2105079905 countsByYear W21050799052016 @default.
• W2105079905 countsByYear W21050799052017 @default.
• W2105079905 countsByYear W21050799052018 @default.
• W2105079905 countsByYear W21050799052023 @default.
• W2105079905 crossrefType "journal-article" @default.
• W2105079905 hasAuthorship W2105079905A5002774261 @default.
• W2105079905 hasAuthorship W2105079905A5006134549 @default.
• W2105079905 hasAuthorship W2105079905A5021029688 @default.
• W2105079905 hasAuthorship W2105079905A5023064016 @default.
• W2105079905 hasAuthorship W2105079905A5024390284 @default.
• W2105079905 hasAuthorship W2105079905A5039227763 @default.
• W2105079905 hasAuthorship W2105079905A5047120478 @default.
• W2105079905 hasAuthorship W2105079905A5047806967 @default.
• W2105079905 hasAuthorship W2105079905A5057196933 @default.
• W2105079905 hasAuthorship W2105079905A5058287032 @default.
• W2105079905 hasAuthorship W2105079905A5073776230 @default.
• W2105079905 hasAuthorship W2105079905A5077357181 @default.
• W2105079905 hasAuthorship W2105079905A5084475433 @default.
• W2105079905 hasAuthorship W2105079905A5086465061 @default.
• W2105079905 hasAuthorship W2105079905A5090391845 @default.
• W2105079905 hasConcept C137061746 @default.
• W2105079905 hasConcept C141071460 @default.
• W2105079905 hasConcept C147483822 @default.
• W2105079905 hasConcept C154317977 @default.
• W2105079905 hasConcept C159047783 @default.
• W2105079905 hasConcept C167672396 @default.
• W2105079905 hasConcept C188280979 @default.
• W2105079905 hasConcept C202751555 @default.
• W2105079905 hasConcept C203014093 @default.
• W2105079905 hasConcept C2776090121 @default.
• W2105079905 hasConcept C2779053233 @default.
• W2105079905 hasConcept C2911091166 @default.
• W2105079905 hasConcept C55493867 @default.
• W2105079905 hasConcept C71924100 @default.
• W2105079905 hasConcept C79484868 @default.

• next